Close

Sarepta Therapeutics (SRPT) Doses First Patient in SRP-4045, SRP-4053 Phase 3 Trial

Go back to Sarepta Therapeutics (SRPT) Doses First Patient in SRP-4045, SRP-4053 Phase 3 Trial